Thursday, May 11, 2006

Mood Disorder Drugs

FDA Safety Changes: Effexor, Effexor XR, Depakene

The FDA has approved revisions to the safety labeling for venlafaxine tablets and extended-release capsules (Effexor and Effexor XR) and valproic acid capsules/syrup (Depakene).

Medscape Medical News 2006

No comments: